Effect of thrombolytic catheter injection of tirofiban and adenosine triphosphate on emergency PCI in patients with severe thrombotic acute anterior myocardial infarction
Zhilong Li,Wanhong Wang,Hao Ding,Ronglin Zhang,Hao Zhou
DOI: https://doi.org/10.3969/j.issn.1674-4055.2019.02.13
2019-01-01
Abstract:Objective To investigate the effects of intracoronary injection of tirofiban and adenosine triphosphate on myocardial perfusion and clinical prognosis in patients with severe anterior myocardial infarction with severe thrombus stress during emergency percutaneous coronary intervention (PCI). Methods Between January 2015 and December 2017, 162 patients with acute anterior wall myocardial infarction who underwent emergency coronary angiography in the Department of Cardiology, Suqian People's Hospital of Nanjing Drum Tower Hospital Group, were selected as subjects. At the time of emergency PCI, patients were randomized into a simple thrombus aspiration group (group A, n=54), thrombus aspiration combined with intracoronary injection of tirofiban (group B, n=54) and thrombus. Aspiration was combined with intracoronary injection of tirofiban and adenosine triphosphate (group C, n=54). Baseline clinical data, angiographic features before and after primary percutaneous coronary intervention (PCI), percentage of imperfect ST-segment resolution, CK-MB peak value, troponin I peak value, NT-proBNP, left ventricular ejection fraction (LVEF) and major adverse cardiovascular events after PCI among 3 groups were compared. Results There were no significant differences in clinical baseline data and coronary angiography data between the 3 groups (all P>0.05). The proportion of normal blood flow in the corrected blood flow meter frame (CTFC) of the myocardial infarction thrombolysis was higher in group C than in group A and group B (90.7% vs. 68.5%, 74.1%, P<0.05). The proportion of myocardial infarction thrombolysis (MBG) grade 3 in group C was higher than that in group A and group B (88.9% vs. 70.4%, 72.2%, P<0.05). The incidence of adverse ST-segment fallback after electrocardiogram was lower in group C than in group A and group B (7.4% vs. 25.9%, 24.1%, P<0.05). There were no significant differences in the peaks of CK-MB and troponin I between the 3 groups (P>0.05). Postoperative NT-proBNP levels were lower in group C than in group A and group B [(983.8±269.8) ng/L vs. (1145.4±392.5) ng/L, (1125.1±378.1) ng/L, P<0.05]. The LVEF C group was higher than the A group and the B group 5 to 7 days after operation [(52.9±6.7)% vs. (48.9±8.5)%, (49.6±8.3)%, P<0.05]. There were no significant differences in the 30-day mortality, recurrent myocardial infarction rate, and target vessel revascularization (TVR) between the 3 groups (P>0.05), but the total MACEs after surgery. The group C was lower than group A and group B (3.7% vs. 18.5%, 16.7%, P<0.05). There was no significant difference in the proportion of postoperative bleeding events between the 3 groups (P>0.05). Conclusions Comparing with thrombus aspiration alone and thrombus aspiration and intracoronary tirofiban bolus injection, intracoronary bolus injection of tirofiban combined with adenosine triphosphate through thrombus aspiration catheter after thrombus aspiration can get better myocardial reperfusion and heart function and reduce 30-days MACEs after PCI without increasing bleeding complication in patients with acute anterior myocardial infarction and heavy thrombosis burden undergoing primary PCI.